{"transactions":[{"id":1404140,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":87459,"kind":"person","name":"Richardson Garrie","position":1,"cik":"0001999183","reported_name":"Richardson Garrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Revenue Officer"}}],"security":"Common Stock","published_at":"2024-09-18T21:44:44.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":3070,"price":25.12,"value":77118.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-01-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":114773,"source":{"system":"sec-edgar","filing":"0001628280-24-040829","document":"wk-form4_1726695878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024040829/wk-form4_1726695878.xml","form_type":"4"}},{"id":1582782,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":87459,"kind":"person","name":"Richardson Garrie","position":1,"cik":"0001999183","reported_name":"Richardson Garrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Revenue Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:45:06.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":12516,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2024 compensation."}],"balance_after":117843,"source":{"system":"sec-edgar","filing":"0001628280-24-010752","document":"wk-form4_1710294297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010752/wk-form4_1710294297.xml","form_type":"4"}},{"id":1752827,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":87459,"kind":"person","name":"Richardson Garrie","position":1,"cik":"0001999183","reported_name":"Richardson Garrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Revenue Officer"}}],"security":"Common Stock","published_at":"2023-11-01T21:29:41.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":36320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter annually, in 4 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation in connection with their appointment as Chief Revenue Officer."}],"balance_after":105327,"source":{"system":"sec-edgar","filing":"0001628280-23-036051","document":"wk-form4_1698874172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023036051/wk-form4_1698874172.xml","form_type":"4"}}]}